Huma Naseem

Huma Naseem

Auto-generated profile, based on publicly available information

Huma Naseem

Faculty of Pharmacy, Ziauddin University, Karachi 75600, Pakistan

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 July 2014 in BioMed Research International
Verified
Journal Article
Open access
PDF file
FSFarhan Ahmed Siddiqui
Farhan Ahmed Siddiqui
NSNawab Sher
Nawab Sher
NSNighat Shafi
Nighat Shafi
ASAlisha Wafa Sial
Alisha Wafa Sial
MAMansoor Ahmad
Mansoor Ahmad
HNHuma Naseem
Huma Naseem
RP-HPLC ultraviolet detection simultaneous quantification of piracetam and levetiracetam has been developed and validated. The chromatography was obtained on a Nucleosil C18 column of25 cm×0.46 cm, 10 μm, dimension. The mobile phase was a (70 : 30 v/v) mixture of 0.1 g/L of triethylamine and acetonitrile. Smooth flow of mobile phase at 1 mL/min was set and 205 nm wavelength was selected. Results were evaluated through statistical parameters which qualify the method reproducibility and selectivity for the quantification of piracetam, levetiracetam, and their impurities hence proving stability-indicating properties. The proposed method is significantly important, permitting the separation of the main constituent piracetam from levetiracetam. Linear behavior was observed between 20 ng/mL and 10000 ng/mL for both drugs. The proposed method was checked in bulk drugs, dosage formulations, physiological condition, and clinical investigations and excellent outcome was witnessed.

1 January 2013 in Journal of Chemistry
Verified
Journal Article
Open access
PDF file
NSNighat Shafi
Nighat Shafi
FSFarhan Ahmed Siddiqui
Farhan Ahmed Siddiqui
HNHuma Naseem
Huma Naseem
NSNawab Sher
Nawab Sher
AZArif Zubair
Arif Zubair
MBMirza Tasawer Baig
Mirza Tasawer Baig
This review article recapitulates the analytical methods for the quantitative determinations of diltiazem and three H2 receptor antagonists (cimetidine, ranitidine, and famotidine) by one of the spectroscopic technique (UV spectrophotometery) and separation technique such as high‐performance liquid chromatography (HPLC). The clinical and pharmaceutical analysis of these drugs requires effective analytical procedures for quality control, pharmaceutical dosage formulations, and biological fluids. An extensive survey of the literature published in various analytical and pharmaceutical chemistry‐related journals has been compiled in its review. A synopsis of reported spectrophotometric and high‐performance liquid chromatographic methods for individual drug is integrated. This appraisal illustrates that majority of the HPLC methods reviewed are based on the quantitative analysis of drugs in biological fluids, and they are appropriate for therapeutic drug monitoring purpose.

1 August 2026 in Letters in Drug Design & Discovery
Verified
Journal Article
Open access
HNHuma Naseem
Huma Naseem
NMNousheen Mushtaq
Nousheen Mushtaq
ZUZaheer Ul-Haq
Zaheer Ul-Haq